REVIEW
Breast cancer: an up-to-date review and future perspectives
Ruoxi Hong, Binghe Xu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 9/8/2022 doi:10.1002/cac2.12358
REVIEW
Non-small cell lung cancer in China
Peixin Chen, Yunhuan Liu, Yaokai Wen, Caicun Zhou
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 9/8/2022 doi:10.1002/cac2.12359
REVIEW
Tumor-associated macrophages in liver cancer: From mechanisms to therapy
Kun Cheng, Ning Cai, Jinghan Zhu, Xing Yang, Huifang Liang, Wanguang Zhang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 9/7/2022 doi:10.1002/cac2.12345
ORIGINAL ARTICLE
AIMP1 promotes multiple myeloma malignancy through interacting with ANP32A to mediate histone H3 acetylation
Rongfang Wei, Yan Zhu, Yuanjiao Zhang, Wene Zhao, Xichao Yu, Ling Wang, Chunyan Gu, Xiaosong Gu, Ye Yang
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/30/2022 doi:10.1002/cac2.12356
LETTER TO THE EDITOR
Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types
Huakang Tu, Yuanqing Ye, Maosheng Huang, Kunlin Xie, Wong-Ho Chow, Hua Zhao, Xifeng Wu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/30/2022 doi:10.1002/cac2.12357
ORIGINAL ARTICLE
PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop
Xinyuan Zhao, Dalong Shu, Wenjuan Sun, Shanshan Si, Wei Ran, Bing Guo, Li Cui
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/24/2022 doi:10.1002/cac2.12349
LETTER TO THE EDITOR
miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies
Iris Garrido-Cano, Anna Adam-Artigues, Ana Lameirinhas, Juan F. Blandez, Vicente Candela-Noguera, Federico Rojo, Sandra Zazo, Juan Madoz-Gúrpide, Ana Lluch, Bego?a Bermejo, Felix Sancenón, Juan Miguel Cejalvo, Ramón Martínez-Má?ez, Pilar Eroles
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/23/2022 doi:10.1002/cac2.12352
LETTER TO THE EDITOR
Evaluation of immune response to anti-COVID-19 booster in cancer patients and chronic medical cannabis users and its association with circulating Eosinophils levels
Cohen Idan, Campisi-Pinto Salvatore, Rozenberg Orit, Abaev Ariel, Khoury Marah, Agbaria Dana, Eitam Harel, Colodner Raul, Khoury Mona, Shalabna Hassan, Samih Yousef, Mahamid Camel, Abu-Amna Mahmoud, Bar-Sela Gil
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/22/2022 doi:10.1002/cac2.12353
LETTER TO THE EDITOR
Peripheral na?ve CD8+ T cells as a predictive biomarker of response to lenvatinib plus an anti-PD-1 antibody in advanced hepatocellular carcinoma: a biomarker study
Cheng Huang, Bin Xu, Xiao-Dong Zhu, Ying-Hao Shen, Mei-Ling Li, Jin-Jin Zhu, Jian Zhou, Jia Fan, Hui-Chuan Sun
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/22/2022 doi:10.1002/cac2.12350
ORIGINAL ARTICLE
A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability
Juhong Wang, Fei Shao, Yannan Yang, Wei Wang, Xueying Yang, Renda Li, Hong Cheng, Sijin Sun, Xiaoli Feng, Yibo Gao, Jie He, Zhimin Lu
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 8/16/2022 doi:10.1002/cac2.12351
